The basal cell carcinoma market is expected to expand over the next decade as rising diagnoses, aging populations and ...

Shares of US drug developer Denali Therapeutics closed up 5.8% at $20.11 yesterday, after it announced a $275 million ...

A Melbourne-based biotech company developing immune-based approaches for Alzheimer’s disease, using extracellular vesicles ...

Ireland incorporated Cosmo Pharmaceuticals saw its shares rise more than 3% to $91.80 yesterday, after it announced ...

The US Food and Drug Administration has approved Bristol Myers Squibb’s Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19 ...

US biotech Vanda Pharmaceuticals (Nasdaq: VNDA) has announced that the American medicines regulator removed a partial ...

A Netherlands-linked biotech company developing targeted protein degraders designed to remove disease-relevant membrane ...

The UK’s BioIndustry Association (BIA) today released its report, From innovation to impact: unlocking patient access to ...

The US Food and Drug Administration (FDA) has announced that Tracy Beth Høeg has been appointed acting director of the Center ...

Accession Therapeutics, a UK clinical-stage biopharmaceutical company developing next generation cancer immunotherapies, ...

A new Australian biotech, Evinco Therapeutics, has launched in Melbourne to advance immune-based treatments for Alzheimer’s ...

US rare diseases focused biotech Capricor Therapeutics shares closed up 371% at $29.96, having leapt a staggering 500% ...